CONTRACT AWARD NOTICE – OFFICIAL JOURNAL
|
Section I: Contracting Authority
|
I.1)
|
Name, Address and Contact Point(s)
|
|
University of Sussex |
Falmer |
Brighton |
BN1 9RH |
UK |
|
|
|
|
|
|
I.2)
|
Type of contracting Authority and Main Activity or Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No |
Section II: Object of the Contract
|
II.1)
|
Description
|
II.1.1)
|
Title attributed to the contract by the contracting authority
MIROCALS Study Flow cytometry cell subset numeration in human whole blood and monitoring of pNF-H in CSF and plasma samples by ELISA.
|
II.1.2(a))
|
Type of works contract
|
II.1.2(b))
|
Type of supplies contract
|
II.1.2(c))
|
Type of service contract8
|
II.1.2)
|
Main site or location of works, place of delivery or performance
|
II.1.3)
|
This notice involves a framework agreement
|
II.1.4)
|
Short description of the contract or purchase(s)
The Service Provider is requested to monitor the absolute number and frequency of circulating white blood cell subsets including FOXP3+ regulatory T cells (Tregs), CD3+, CD4+, CD8+, B, and NK cells in EDTA whole blood samples and the circulating pNF-H bio-marker in CSF and plasma.
For whole blood samples, cell subsets should be analysed by flow cytometry. There will be 216 patients and 5 time points per patient (1 080 samples in total).
For plasma and CSF samples, the pNF-H should be monitored using a commercial ELISA kit (Biovendor). There will be 3 plasma samples + 3 CSF samples per patient from 216 patients (2 x 3 x 216 = 1296 samples in total).
All procedures will need to be validated, including the pre-analytical stability of whole blood samples prior to flow cytometry analysis.
|
II.1.5)
|
Common Procurement Vocabulary (CPV)
|
|
|
|
73111000 |
|
|
|
|
|
II.1.6)
|
Contract covered by the government procurement agreement (GPA) Yes |
II.2)
|
Total final value of the contract(s)
|
II.2.1)
|
Total final value of the contract(s)
|
Section IV: Procedure
|
IV.1)
|
Type of procedure
|
IV.1.1)
|
Type of procedure |
IV.2)
|
Award criteria
|
IV.2.1)
|
Award criteria
|
IV.2.2)
|
An electronic auction has been used No
|
IV.3)
|
Administrative information
|
IV.3.1)
|
File reference number attributed by the contracting authority
US_16022
|
IV.3.2)
|
Previous publication(s) concerning the same contract
Other previous publications
|
Section V: Award of contract
|
|
|
V.1)
|
Date of contract award: 16-10-2016 |
V.2)
|
Numbers of offers received:2 |
V.3)
|
Name and address of economic operator to whom the contract has been awarded
BioCytex |
140 chemin de l'Armée d'Afrique |
Marseille |
13010 |
FR |
|
|
|
|
|
V.4)
|
Information on value of contract |
V.5)
|
The contract is likely to be subcontracted No
|
|
Short description of the value/proportion of the contract to be subcontracted
|
Section VI: Complementary Information
|
VI.1)
|
Contract related to a project and/or programme financed by community funds? No
|
VI.2)
|
Additional Information
|
VI.3)
|
Procedures for appeal
|
VI.3.1)
|
Body responsible for appeal procedures
|
|
|
|
|
|
|
|
|
|
|
Body responsible for mediation procedures
|
|
|
|
|
|
|
|
|
|
VI.3.2)
|
Lodging of appeals
|
VI.3.3)
|
Service from which information about the lodging of appeals may be obtained
|
|
|
|
|
|
|
|
|
|
VI.4)
|
Dispatch date of this Notice 23-11-2016 |